Literature DB >> 9185714

A lymphocyte cell surface heat shock protein homologous to the endoplasmic reticulum chaperone, immunoglobulin heavy chain binding protein BIP.

C L Berger1, Z Dong, D Hanlon, E Bisaccia, R L Edelson.   

Abstract

BE2 is a cell surface monomeric 78-kDa protein (BE2-78) expressed on the malignant lymphocytes of cutaneous T-cell lymphoma and adult T-cell leukemia, on some lymphocytes from patients with acquired immunodeficiency syndrome and on Epstein-Barr virus-transformed B cells. BE2-78 positivity of cutaneous T-cell lymphoma tumor cells is a useful diagnostic and prognostic determinant in evaluating patients with that disorder. The BE2-78 protein was isolated from Epstein Barr virus-transformed B cells, purified by 1- and 2-dimensional electrophoresis and then sequenced. The sequence of 4 isolated peptide fragments was highly homologous with the 78-kDa heat shock protein, BiP, an endoplasmic reticulum chaperone. The similarity between BiP and BE2-78 was supported by the demonstration that BE2-78, like BiP, avidly binds to ATP. However, polyclonal and monoclonal reagents that recognize cytoplasmic 70- and 78-kDa heat shock proteins do not detect the BE2-78 antigen on the cell surface of cutaneous T-cell lymphoma or Epstein Barr virus-transformed lymphocytes, and peptide mapping demonstrates sequence divergence, suggesting that either they are distinct or conformationally different molecules. Our results indicate that BE2-78 is a cell surface heat shock protein. The possibility that malignant or transformed lymphocytes may express cell surface molecules with the capacity to bind a spectrum of exogenous or endogenous peptides has potential implications for tumor immunology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185714     DOI: 10.1002/(sici)1097-0215(19970611)71:6<1077::aid-ijc26>3.0.co;2-9

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Molecular chaperones in the etiology and therapy of cancer.

Authors:  C Soti; P Csermely
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 2.  Chaperone proteins and brain tumors: potential targets and possible therapeutics.

Authors:  Michael W Graner; Darell D Bigner
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

Review 3.  Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting.

Authors:  Min Ni; Yi Zhang; Amy S Lee
Journal:  Biochem J       Date:  2011-03-01       Impact factor: 3.857

4.  Mesencephalic astrocyte-derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors.

Authors:  Mark J Henderson; Christopher T Richie; Mikko Airavaara; Yun Wang; Brandon K Harvey
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

5.  Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction.

Authors:  M Chen; Y Zhang; V C Yu; Y-S Chong; T Yoshioka; R Ge
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

6.  Association of stress proteins with autoantigens: a possible mechanism for triggering autoimmunity?

Authors:  A W Purcell; A Todd; G Kinoshita; T A Lynch; C L Keech; M-J Gething; T P Gordon
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

7.  The Escherichia coli subtilase cytotoxin A subunit specifically cleaves cell-surface GRP78 protein and abolishes COOH-terminal-dependent signaling.

Authors:  Rupa Ray; Gustaaf G de Ridder; Jerry P Eu; Adrienne W Paton; James C Paton; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

8.  Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders.

Authors:  Miao Wang; Shiuan Wey; Yi Zhang; Risheng Ye; Amy S Lee
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

9.  Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.

Authors:  Qing Shao; Pengfei Ren; Yang Li; Bo Peng; Liping Dai; Ningjing Lei; Wu Yao; Gang Zhao; Linggen Li; Jianying Zhang
Journal:  Int J Oncol       Date:  2012-06-12       Impact factor: 5.650

10.  The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer.

Authors:  Michael W Hance; Krystal D Nolan; Jennifer S Isaacs
Journal:  Cancers (Basel)       Date:  2014-05-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.